Novo Nordisk A/S (NVO)

USD 105.96

(-1.9%)

Eps Summary of Novo Nordisk A/S

  • Novo Nordisk A/S's latest annual eps in 2023 was 18.62 DKK , up 52.28% from previous year.
  • Novo Nordisk A/S's latest quarterly eps in 2024 Q2 was 4.50 DKK , down -21.23% from previous quarter.
  • Novo Nordisk A/S reported an annual eps of 12.26 DKK in 2022, up 17.88% from previous year.
  • Novo Nordisk A/S reported an annual eps of 10.40 DKK in 2021, up 15.17% from previous year.
  • Novo Nordisk A/S reported a quarterly eps of 5.70 DKK for 2024 Q1, up 15.85% from previous quarter.
  • Novo Nordisk A/S reported a quarterly eps of 4.92 DKK for 2023 Q4, down -1.99% from previous quarter.

Annual Eps Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Eps of Novo Nordisk A/S (2023 - 1989)

Year Eps Eps Growth
2023 18.62 DKK 52.28%
2022 12.26 DKK 17.88%
2021 10.40 DKK 15.17%
2020 9.03 DKK 10.12%
2019 8.20 DKK 2.76%
2018 7.98 DKK 3.5%
2017 7.71 DKK 2.8%
2016 7.50 DKK -44.69%
2015 13.56 DKK 34.26%
2014 10.10 DKK 7.45%
2013 9.40 DKK 20.2%
2012 7.82 DKK 29.26%
2011 6.05 DKK 21.98%
2010 4.96 DKK 38.16%
2009 3.59 DKK 14.7%
2008 3.13 DKK 15.5%
2007 2.71 DKK 34.83%
2006 2.01 DKK 12.92%
2005 1.78 DKK 19.46%
2004 1.49 DKK 4.2%
2003 1.43 DKK 21.19%
2002 1.18 DKK 5.36%
2001 1.12 DKK 25.84%
2000 0.89 DKK 28.99%
1999 0.69 DKK 35.29%
1998 0.51 DKK -13.56%
1997 0.59 DKK 22.92%
1996 0.48 DKK 14.29%
1995 0.42 DKK 10.53%
1994 0.38 DKK 0.0%
1993 0.38 DKK 11.76%
1992 0.34 DKK 6.25%
1991 0.32 DKK 33.33%
1990 0.24 DKK 26.32%
1989 0.19 DKK -24.0%

Peer Eps Comparison of Novo Nordisk A/S

Name Eps Eps Difference
ADC Therapeutics SA -2.94 USD 733.333%
Alto Neuroscience, Inc. -1.35 USD 1479.259%
Annovis Bio, Inc. -6.23 USD 398.876%
Biohaven Pharmaceutical Holding Company Ltd. -5.73 USD 424.956%
Ginkgo Bioworks Holdings, Inc. -18.37 USD 201.361%
Nuvation Bio Inc. -0.35 USD 5420.0%
Nuvation Bio Inc. -0.35 USD 5420.0%
Arcus Biosciences, Inc. -4.15 USD 548.675%
Theriva Biologics, Inc. -28.49 USD 165.356%
Zymeworks Inc. -1.72 USD 1182.558%